Celogics is a leading manufacturer of high-quality human induced pluripotent stem cell products, located in the Greater Seattle Area. Their precisely designed functional iPSC-derived cardiomyocytes are validated in multiple platforms, offering a serum-free media to maintain their functionality and electrophysiology under various conditions.
With a focus on providing validated data, good communication, and uncompromising quality, Celogics aims to become the go-to manufacturer for next-generation cell models, catering to disease modeling, drug discovery, and drug safety screening applications.
Generated from the website